Skip to main content
Top
Published in:

Open Access 01-12-2023 | Acute Respiratory Distress Syndrome | Correspondence

Comprehensive bronchoalveolar lavage characterization in COVID-19 associated acute respiratory distress syndrome patients: a prospective cohort study

Authors: Fiorella Calabrese, Francesca Lunardi, Elisa Baldasso, Federica Pezzuto, Asuman Kilitci, Gheorghe-Emilian Olteanu, Claudia Del Vecchio, Francesco Fortarezza, Annalisa Boscolo, Marco Schiavon, Luca Vedovelli, Annamaria Cattelan, Dario Gregori, Federico Rea, Paolo Navalesi

Published in: Respiratory Research | Issue 1/2023

Login to get access

Abstract

COVID-19-related acute respiratory distress syndrome (CARDS) is associated with high mortality rates. We still have limited knowledge of the complex alterations developing in the lung microenvironment. The goal of the present study was to comprehensively analyze the cellular components, inflammatory signature, and respiratory pathogens in bronchoalveolar lavage (BAL) of CARDS patients (16) in comparison to those of other invasively mechanically ventilated patients (24). In CARDS patients, BAL analysis revealed: SARS-CoV-2 infection frequently associated with other respiratory pathogens, significantly higher neutrophil granulocyte percentage, remarkably low interferon-gamma expression, and high levels of interleukins (IL)-1β and IL-9. The most important predictive variables for worse outcomes were age, IL-18 expression, and BAL neutrophilia. To the best of our knowledge, this is the first study that was able to identify, through a comprehensive analysis of BAL, several aspects relevant to the complex pathophysiology of CARDS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Karagiannidis C, Mostert C, Hentschker C, Voshaar T, Malzahn J, Schillinger G, et al. Case characteristics, resource use, and outcomes of 10,021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med. 2020;8:853–62.CrossRefPubMedPubMedCentral Karagiannidis C, Mostert C, Hentschker C, Voshaar T, Malzahn J, Schillinger G, et al. Case characteristics, resource use, and outcomes of 10,021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med. 2020;8:853–62.CrossRefPubMedPubMedCentral
2.
go back to reference Boscolo A, Sella N, Lorenzoni G, Pettenuzzo T, Pasin L, Pretto C, et al. Static compliance and driving pressure are associated with ICU mortality in intubated COVID-19 ARDS. Crit Care. 2021;25:263.CrossRefPubMedPubMedCentral Boscolo A, Sella N, Lorenzoni G, Pettenuzzo T, Pasin L, Pretto C, et al. Static compliance and driving pressure are associated with ICU mortality in intubated COVID-19 ARDS. Crit Care. 2021;25:263.CrossRefPubMedPubMedCentral
3.
go back to reference Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34:327–31.PubMed Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34:327–31.PubMed
4.
go back to reference Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25–32.CrossRefPubMedPubMedCentral Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25–32.CrossRefPubMedPubMedCentral
5.
go back to reference Zaid Y, Doré É, Dubuc I, Archambault AS, Flamand O, Laviolette M, et al. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19. J Allergy Clin Immunol. 2021;148:368-80e3.CrossRefPubMedPubMedCentral Zaid Y, Doré É, Dubuc I, Archambault AS, Flamand O, Laviolette M, et al. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19. J Allergy Clin Immunol. 2021;148:368-80e3.CrossRefPubMedPubMedCentral
6.
go back to reference Famous KR, Delucchi K, Ware LB, Kangelaris KN, Liu KD, Thompson BT, et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med. 2017;195:331–8.CrossRefPubMedPubMedCentral Famous KR, Delucchi K, Ware LB, Kangelaris KN, Liu KD, Thompson BT, et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med. 2017;195:331–8.CrossRefPubMedPubMedCentral
7.
go back to reference Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J, et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med. 2020;26:842–4.CrossRefPubMed Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J, et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med. 2020;26:842–4.CrossRefPubMed
8.
go back to reference Saris A, Reijnders TDY, Nossent EJ, Schuurman AR, Verhoeff J, Asten SV, et al. Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19. Thorac Surg Clin. 2021;76:1010–9. Saris A, Reijnders TDY, Nossent EJ, Schuurman AR, Verhoeff J, Asten SV, et al. Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19. Thorac Surg Clin. 2021;76:1010–9.
9.
go back to reference Patrucco F, Albera C, Bellocchia M, Foci V, Gavelli F, Castello LM, et al. SARS-CoV-2 detection on Bronchoalveolar Lavage: an italian multicenter experience. Respiration. 2020;99:970–8.CrossRefPubMed Patrucco F, Albera C, Bellocchia M, Foci V, Gavelli F, Castello LM, et al. SARS-CoV-2 detection on Bronchoalveolar Lavage: an italian multicenter experience. Respiration. 2020;99:970–8.CrossRefPubMed
10.
go back to reference Dentone C, Vena A, Loconte M, Grillo F, Brunetti I, Barisione E, et al. Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy. BMC Infect Dis. 2021;21:353.CrossRefPubMedPubMedCentral Dentone C, Vena A, Loconte M, Grillo F, Brunetti I, Barisione E, et al. Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy. BMC Infect Dis. 2021;21:353.CrossRefPubMedPubMedCentral
11.
go back to reference Baron A, Hachem M, Van Tran J, Botterel F, Fourati S, Carteaux G, et al. Bronchoalveolar Lavage in patients with COVID-19 with invasive mechanical ventilation for acute respiratory distress syndrome. Ann Am Thorac Soc. 2021;18:723–6.CrossRefPubMedPubMedCentral Baron A, Hachem M, Van Tran J, Botterel F, Fourati S, Carteaux G, et al. Bronchoalveolar Lavage in patients with COVID-19 with invasive mechanical ventilation for acute respiratory distress syndrome. Ann Am Thorac Soc. 2021;18:723–6.CrossRefPubMedPubMedCentral
12.
go back to reference Cambier S, Metzemaekers M, de Carvalho AC, Nooyens A, Jacobs C, Vanderbeke L, et al. Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza. JCI Insight. 2022;7:e155055.CrossRefPubMedPubMedCentral Cambier S, Metzemaekers M, de Carvalho AC, Nooyens A, Jacobs C, Vanderbeke L, et al. Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza. JCI Insight. 2022;7:e155055.CrossRefPubMedPubMedCentral
13.
go back to reference Sulaiman I, Chung M, Angel L, Tsay JJ, Wu BG, Yeung ST, et al. Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome. Nat Microbiol. 2021;6:1245–58.CrossRefPubMedPubMedCentral Sulaiman I, Chung M, Angel L, Tsay JJ, Wu BG, Yeung ST, et al. Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome. Nat Microbiol. 2021;6:1245–58.CrossRefPubMedPubMedCentral
14.
go back to reference Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21:e149-62.CrossRefPubMed Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21:e149-62.CrossRefPubMed
15.
go back to reference Alanio A, Dellière S, Fodil S, Bretagne S, Mégarbane B. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med. 2020;8:e48-9.CrossRefPubMed Alanio A, Dellière S, Fodil S, Bretagne S, Mégarbane B. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med. 2020;8:e48-9.CrossRefPubMed
16.
go back to reference Viciani E, Gaibani P, Castagnetti A, Liberatore A, Bartoletti M, Viale P, et al. Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp. Int J Infect Dis. 2022;117:233–40.CrossRefPubMedPubMedCentral Viciani E, Gaibani P, Castagnetti A, Liberatore A, Bartoletti M, Viale P, et al. Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp. Int J Infect Dis. 2022;117:233–40.CrossRefPubMedPubMedCentral
18.
go back to reference Lucas C, Wong P, Klein J, Castro TBR, Silva J, Sundaram M, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584:463–9.CrossRefPubMedPubMedCentral Lucas C, Wong P, Klein J, Castro TBR, Silva J, Sundaram M, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584:463–9.CrossRefPubMedPubMedCentral
19.
go back to reference Sposito B, Broggi A, Pandolfi L, Crotta S, Clementi N, Ferrarese R, et al. The interferon landscape along the respiratory tract impacts the severity of COVID-19. Cell. 2021;184:4953-68e16.CrossRefPubMedPubMedCentral Sposito B, Broggi A, Pandolfi L, Crotta S, Clementi N, Ferrarese R, et al. The interferon landscape along the respiratory tract impacts the severity of COVID-19. Cell. 2021;184:4953-68e16.CrossRefPubMedPubMedCentral
20.
go back to reference Ward JD, Cornaby C, Schmitz JL. Indeterminate QuantiFERON gold plus results reveal deficient Interferon Gamma responses in severely ill COVID-19 patients. J Clin Microbiol. 2021;59:e0081121.CrossRefPubMed Ward JD, Cornaby C, Schmitz JL. Indeterminate QuantiFERON gold plus results reveal deficient Interferon Gamma responses in severely ill COVID-19 patients. J Clin Microbiol. 2021;59:e0081121.CrossRefPubMed
21.
go back to reference Feng Y, Yu M, Zhu F, Zhang S, Ding P, Wang M. IL-9 promotes the development of deep venous thrombosis by facilitating platelet function. Thromb Haemost. 2018;118:1885–94.CrossRefPubMed Feng Y, Yu M, Zhu F, Zhang S, Ding P, Wang M. IL-9 promotes the development of deep venous thrombosis by facilitating platelet function. Thromb Haemost. 2018;118:1885–94.CrossRefPubMed
22.
go back to reference Calabrese F, Pezzuto F, Fortarezza F, Boscolo A, Lunardi F, Giraudo C, et al. Machine learning-based analysis of alveolar and vascular injury in SARS-CoV-2 acute respiratory failure. J Pathol. 2021;254:173–84.CrossRefPubMedPubMedCentral Calabrese F, Pezzuto F, Fortarezza F, Boscolo A, Lunardi F, Giraudo C, et al. Machine learning-based analysis of alveolar and vascular injury in SARS-CoV-2 acute respiratory failure. J Pathol. 2021;254:173–84.CrossRefPubMedPubMedCentral
23.
go back to reference Fortarezza F, Pezzuto F, Hofman P, Kern I, Panizo A, von der Thüsen J, et al. COVID-19 pulmonary pathology: the experience of European pulmonary pathologists throughout the first two waves of the pandemic. Diagnostics (Basel). 2022;12:95.CrossRefPubMed Fortarezza F, Pezzuto F, Hofman P, Kern I, Panizo A, von der Thüsen J, et al. COVID-19 pulmonary pathology: the experience of European pulmonary pathologists throughout the first two waves of the pandemic. Diagnostics (Basel). 2022;12:95.CrossRefPubMed
24.
go back to reference Zarrilli G, Angerilli V, Businello G, Sbaraglia M, Traverso G, Fortarezza F, et al. The immunopathological and histological Landscape of COVID-19-Mediated Lung Injury. Int J Mol Sci. 2021;22:974.CrossRefPubMedPubMedCentral Zarrilli G, Angerilli V, Businello G, Sbaraglia M, Traverso G, Fortarezza F, et al. The immunopathological and histological Landscape of COVID-19-Mediated Lung Injury. Int J Mol Sci. 2021;22:974.CrossRefPubMedPubMedCentral
25.
go back to reference Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574–81.CrossRefPubMedPubMedCentral Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574–81.CrossRefPubMedPubMedCentral
26.
go back to reference Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Crit Care Med. 2020;48:e440-69.CrossRefPubMed Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Crit Care Med. 2020;48:e440-69.CrossRefPubMed
27.
go back to reference Vaschetto R, Barone-Adesi F, Racca F, Pissaia C, Maestrone C, Colombo D, et al. Outcomes of COVID-19 patients treated with continuous positive airway pressure outside the intensive care unit. ERJ Open Res. 2021;7:00541–2020.CrossRefPubMedPubMedCentral Vaschetto R, Barone-Adesi F, Racca F, Pissaia C, Maestrone C, Colombo D, et al. Outcomes of COVID-19 patients treated with continuous positive airway pressure outside the intensive care unit. ERJ Open Res. 2021;7:00541–2020.CrossRefPubMedPubMedCentral
Metadata
Title
Comprehensive bronchoalveolar lavage characterization in COVID-19 associated acute respiratory distress syndrome patients: a prospective cohort study
Authors
Fiorella Calabrese
Francesca Lunardi
Elisa Baldasso
Federica Pezzuto
Asuman Kilitci
Gheorghe-Emilian Olteanu
Claudia Del Vecchio
Francesco Fortarezza
Annalisa Boscolo
Marco Schiavon
Luca Vedovelli
Annamaria Cattelan
Dario Gregori
Federico Rea
Paolo Navalesi
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2023
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-023-02464-9

Other articles of this Issue 1/2023

Respiratory Research 1/2023 Go to the issue

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more